National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$69.95
add to cart

Rights & Permissions

topleft topright

Dietary Reference Intakes for Calcium and Vitamin D (2011)
Food and Nutrition Board (FNB)

Citation Manager

. "4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D." Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.

Please select a format:

BibTeX EndNote RefMan


Page
250
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


DRI Dietary Reference Intakes Calcium Vitamin D

ionized calcium (i.e., the physiologically important fraction of calcium) and the albumin-corrected serum calcium levels do not change during pregnancy (Seely et al., 1997). Pregnant women consuming “moderate” calcium (800 to 1,000 mg/day) (Gertner et al., 1986; Allen et al., 1991) to “high” calcium (1,950 mg/day) (Cross et al., 1995) are often hypercalciuric as a result of increased intestinal calcium absorption (i.e., absorptive hypercalciuria); as such, pregnancy itself is a risk factor for kidney stones. Urinary calcium excretion increases as early as the 12th week of gestation and averages 300 ± 61 mg/24 hours in the third trimester with hypercalciuric levels not uncommon (Pedersen et al., 1984; Gertner et al., 1986; Allen et al., 1991; Cross et al., 1995; Seely et al., 1997). While urinary calcium excretion goes up in normal pregnancy, it decreases in women who are developing preeclampsia. The risk of preeclampsia can be reduced with supplemental calcium when the dietary calcium intake is very low; however, there appears to be no effect when dietary calcium intake is adequate (Hofmeyr et al., 2006; Villar et al., 2006; Hiller et al., 2007; Kumar et al., 2009).

In the adolescent, whose skeleton is still growing, pregnancy could theoretically reduce peak bone mass and increase the long-term risk of osteoporosis. Most cross–sectional studies that have compared the BMD in teens early postpartum with that in never-pregnant teens have suggested that there is no reason to be concerned about BMD or bone mass after adolescent pregnancy (Kovacs and Kronenberg, 1997). A few smaller observational studies have reported that lower adolescent age at first pregnancy is associated with lower BMD in the adult (Sowers et al., 1985, 1992; Fox et al., 1993). In contrast, an analysis of NHANES III data on BMD by DXA for 819 women ages 20 to 25 years found that women pregnant as adolescents had the same BMD as women pregnant as adults and as nulliparous women (Chantry et al., 2004). This study’s population is diverse and representative of the general U.S. population and thus reassures that teen pregnancy does not reduce BMD in most women. An additional study (O’Brien et al., 2003) found that fractional calcium absorption doubles during adolescent pregnancy (as it does in adults) and during the first 2 months postpartum. Mean BMD of previously pregnant—but not lactating—adolescents was above the expected BMD for age in this study, also suggesting that no loss of BMD had occurred during pregnancy. These data indicate that adolescent women meet the calcium demands of pregnancy by increasing intestinal calcium absorption while preserving maternal bone mass.


Pregnancy: Vitamin D

Maternal outcomes Total calcitriol levels double early in pregnancy and remain at this increased level until delivery (Bikle et al., 1984; Cross et al., 1995; Ardawi et al., 1997; O’Brien et al., 2006; Papapetrou, 2010).

Page
250
Front Matter (R1-R16)
Summary (1-14)
1 Introduction (15-34)
2 Overview of Calcium (35-74)
3 Overview of Vitamin D (75-124)
4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D (125-344)
5 Dietary Reference Intakes for Adequacy: Calcium and Vitamin D (345-402)
6 Tolerable Upper Intake Levels: Calcium and Vitamin D (403-456)
7 Dietary Intake Assessment (457-478)
8 Implications and Special Concerns (479-512)
9 Information Gaps and Research Needs (513-522)
Appendix A: Acronyms, Abbreviations, and Glossary (523-536)
Appendix B: Issues and Interests Identified by Study Sponsors (537-538)
Appendix C: Methods and Results from the AHRQ-Ottawa Evidence-Based Report on Effectiveness and Safety of Vitamin D in Relation to Bone Health (539-724)
Appendix D: Methods and Results from the AHRQ-Tufts Evidence-Based Report on Vitamin D and Calcium (725-1012)
Appendix E: Literature Search Strategy (1013-1018)
Appendix F: Evidence Maps (1019-1024)
Appendix G: Cases Studies of Vitamin D Toxicity (1025-1034)
Appendix H: Estimated Intakes of Calcium and Vitamin D from National Surveys (1035-1044)
Appendix I: Proportion of the Population Above and Below 40 nmol/L Serum 25-Hydroxyvitamin D Concentrations and Cumulative Distribution of Serum 25-Hydroxyvitamin D Concentrations: United States and Canada (1045-1058)
Appendix J: Workshop Agenda and Open Session Agendas (1059-1064)
Appendix K: Biographical Sketches of Committee Members (1065-1074)
Index (1075-1102)
Summary Tables: Dietary Reference Intakes (1103-1116)